S. Gretton

发表

Strong opioids in cancer pain : clinical and pharmacogenetic factors influencing an individual's response to morphine and oxycodone

S. Gretton, 2010 .

The genetic influences on oxycodone response characteristics in human experimental pain

L. Arendt-Nielsen, A. Drewes, C. Staahl, 2015, Fundamental & clinical pharmacology.

Plasma morphine and metabolite concentrations are associated with clinical effects of morphine in cancer patients.

S. Joel, J. Droney, Hiroe Sato, 2013, Journal of pain and symptom management.

Splice variation of the mu-opioid receptor and its effect on the action of opioids

J. Droney, S. Gretton, 2014, British journal of pain.

Constipation in cancer patients on morphine

J. Droney, Hiroe Sato, J. Ross, 2008, Supportive Care in Cancer.

Morphine or oxycodone for cancer-related pain? A randomized, open-label, controlled trial.

A. Wells, M. Thick, J. Droney, 2015, Journal of pain and symptom management.

Analgesia and central side-effects: two separate dimensions of morphine response.

J. Droney, Hiroe Sato, J. Ross, 2013, British journal of clinical pharmacology.

Genetic variation and response to morphine in cancer patients

R. D. du Bois, Hiroe Sato, J. Ross, 2008, Cancer.

Morphine metabolites: a review of their clinical effects

S. Gretton, J. Riley, 2008 .

An overview of opioids in palliative care: Part 1

J. Ross, J. Riley, A. Stevens, 2006 .

Morphine or oxycodone for cancer-related pain? A randomized, open-label, controlled trial.

A. Wells, M. Thick, J. Droney, 2015, Journal of pain and symptom management.